- Merck acquired Acceleron Pharma, a company developing drugs to treat cardiovascular and other blood-related disorders, for about $11.5 billion.
- Pfizer is acquiring Arena Pharmaceuticals, a company developing potential treatments for immuno-inflammatory diseases, for about $6.7 billion.
- AmerisourceBergen acquired Alliance Healthcare, Walgreens Boots Alliance’s wholesaling arm, for $6.5 billion.
- PerkinElmer bought antibody and reagents maker BioLegend for $5.25 billion.
- Sanofi acquired clinical-stage mRNA therapeutics company Translate Bio for about $3.2 billion.
- Pfizer acquired Canadian cancer drugmaker Trillium Therapeutics for $2.26 billion.
- Sanofi acquired drugmaker Kadmon for $1.9 billion.
- Amgen acquired cancer drugmaker Five Prime Therapeutics for about $1.9 billion.
- Merck acquired Pandion Therapeutics, a drugmaker specializing in autoimmune disease treatments, for $1.85 billion.
- Roche acquired GenMark Diagnostics, a company that produces molecular tests that can identify the presence of several different pathogens, for $1.8 billion.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
